Stryker Corporation (SYK)
|Net Income (ttm)||1.90B|
|Ex-Dividend Date||Sep 29, 2021|
|Day's Range||244.34 - 249.67|
|52-Week Range||220.90 - 281.16|
|Price Target||285.86 (+15.8%)|
|Earnings Date||Oct 28, 2021|
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other me... [Read more...]
In 2020, Stryker's revenue was $14.35 billion, a decrease of -3.58% compared to the previous year's $14.88 billion. Earnings were $1.60 billion, a decrease of -23.24%.Financial Statements
According to 30 analysts, the average rating for Stryker stock is "Buy." The 12-month stock price forecast is 285.86, which is an increase of 15.79% from the latest price.
Stryker is one of the largest medical device companies in the world, yet it appears to have plenty of growth left in the tank.
AHCO vs. SYK: Which Stock Is the Better Value Option?
MAHWAH, N.J.--(BUSINESS WIRE)--Stryker launched the Prophecy Infinity Resect-Through Guides for use in total ankle replacement surgeries.
Despite pandemic-led disruptions, Stryker's (SYK) third-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.
Stryker (SYK) delivered earnings and revenue surprises of -3.51% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Stryker (NYSE:SYK) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement.
Kalamazoo, MI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2021:
Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.
We think that Stryker stock (NYSE: SYK) currently is a better pick compared to Boston Scientific stock, despite Stryker being slightly more expensive of the two. Stryker trades at about 6.4x trailing re...
Watch out for the likes of Asensus Surgical (ASXC), Stryker (SYK), Medtronic (MDT) and Intuitive Surgical (ISRG) as demand for surgical robots is set to rise, owing to the conveniences they offer.
Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company'...
OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.
The newly launched Citrelock Tendon Fixation Device System expands Stryker's (SYK) Foot & Ankle offerings.
MAHWAH, N.J.--(BUSINESS WIRE)--Stryker's Trauma & Extremities division has launched its Citrelock™ Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon th...
Medical device companies are gradually seeing a rebound in their business as fewer elective medical visits, procedures and surgeries are being delayed due to Covid-19.
Final Trades: Stryker, Editas Medicine, Oracle & more
The "Halftime Report" traders give their top picks to watch for the second half.
Investors are optimistic about Stryker's (SYK) strength in robotics and its diversified product portfolio.
Stryker Corporation (NYSE: SYK) has acquired Gauss Surgical for an undisclosed consideration. Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabled pla...
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure raises a concern.
FREMONT, Calif., Sept. 1, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Stuart F.
Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Morgan Stanley's 19th Annual Global Healthcare Conference on Monday, September 13, 2021.
MAHWAH, N.J.--(BUSINESS WIRE)--Stryker's T2 Alpha Femur Retrograde Nailing System features a redefined data-driven nail design, a dedicated proximal targeting system, and more.